very different this time
Big Pharma validates Lag-3 in a phase 3 trial of 700 patients.
This is truly a defining point in development of Immutep
very different this timeBig Pharma validates Lag-3 in a phase 3...
-
- There are more pages in this discussion • 57 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $493.8M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 827 | 36.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.5¢ | 828 | 3 |
View Market Depth
| Last trade - 09.54am 16/08/2024 (20 minute delay) ? |
| IMM (ASX) Chart |
Day chart unavailable